Agio Pharmaceuticals Limited, a active public limited company, was established on 24 January 1992 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH1992PLC065031. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹5.18 Cr.
It upholds a compliant status. Employing 343 professional, Its leadership includes Mahendra Kumar Kumawat (Whole-Time Director), Raghav Sanjay Ruia (Whole-Time Director), Madhusudan Govindprasad Ruia (Managing Director). Past directors included Sneha Ahuja, Ravikant F Sharma, Pankaj Nandkishor Chandak. It holds ₹75.02 Cr open charges and ₹205.08 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A-38, Nandjyot Industrial Estate, Kurla Andheri Road, Safed Pool,, Mumbai, Maharashtra, 400072.
U24239MH1992PLC065031
065031
24 January 1992
₹6.00 Cr
₹5.18 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Agio Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahendra Kumar Kumawat | Whole-Time Director | 09 Sep 2020 | Current |
| Raghav Sanjay Ruia | Whole-Time Director | 04 Oct 2019 | Current |
| Madhusudan Govindprasad Ruia | Managing Director | 24 Jan 1992 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Whole-Time Director | 04 Jul 2013 | Past |
| Pramod Abcsdd | Whole-Time Director | 09 Oct 2019 | Past |
| Pramod Abcsdd | Whole-Time Director | 17 Sep 2020 | Past |
| Pramod Abcsdd | Director | 07 Dec 2011 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Agio Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 66.15% increase. The company also saw a substantial improvement in profitability, with a 1772.06% increase in profit. The company's net worth Soared by an impressive increase of 28.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Agio Pharmaceuticals had a promoter holding of 94.86% and a public holding of 5.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹750,155,950.00
₹2,050,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Oct 2025 | Hdfc Bank Limited | ₹4.30 M | Open |
| 28 Nov 2024 | Others | ₹5.80 M | Open |
| 18 Mar 2024 | Sbicap Trustee Company Limited | ₹65.69 Cr | Open |
| 10 Nov 2023 | Others | ₹5.10 M | Open |
| 21 Jul 2023 | Axis Bank Limited | ₹8.00 M | Open |
Explore comprehensive loan charge details -
Agio Pharmaceuticals has a workforce of 343 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Agio Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agio Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.43 Cr with Charge ID 101191467 was registered on 13 Oct 2025. was documented.
Agio Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Agio Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.58 Cr with Charge ID 101019912 was registered on 28 Nov 2024. was completed.
A charge with Sbicap Trustee Company Limited of Rs. 65.69 Cr registered on 18 Mar 2024 with Charge ID 100897901 was modified on 24 Jul 2024. was recorded as a recent event.
A charge with Others of Rs. 0.84 Cr registered on 23 Mar 2011 with Charge ID 10286381 was modified on 29 May 2024. was recorded as a recent event.
The CIN of Agio Pharmaceuticals Limited is U24239MH1992PLC065031.
Agio Pharmaceuticals Limited is headquartered at A-38, Nandjyot Industrial Estate, Kurla Andheri Road, Safed Pool,, Mumbai, Maharashtra, 400072.
Agio Pharmaceuticals Limited was incorporated on 24 January 1992.
The current directors of Agio Pharmaceuticals Limited are
The primary industry of Agio Pharmaceuticals Limited is Manufacturing.
Agio Pharmaceuticals Limited is unlisted.
The authorized capital of Agio Pharmaceuticals Limited is ₹6.00 Cr, and the paid-up capital is ₹5.18 Cr.
The compliance status of Agio Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX